Considering that activation of PXR signaling may induce hypercholesterolemia and cirrhosis, the combination of this finding also suggests that PXR activation should be considered in patients on long-term PXR agonistic antiretroviral drugs (21). Here, NR1I2 is linked to Hypercholesterolemia.